相关实验视频

Updated: Jun 6, 2025

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

抗整体αvβ6抗体作为诊断性结肠炎的生物标志物:全国性的多中心验证研究

Makoto Okabe¹, Shuji Yamamoto², Masahiro Shiokawa³

¹Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Journal of gastroenterology

|November 28, 2024

概括

一种新的抗整体αvβ6抗体 (V6 Ab) 显示出对诊断性结肠炎 (UC) 的前景. 这项大型全国性研究验证了其诊断准确性,证实了其作为UC检测可靠生物标志物的潜力.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
生物标志物发现发现

背景情况:

缺少确定的血清生物标志物来诊断性结肠炎 (UC).
以前的研究表明,抗整体αvβ6抗体 (V6 Ab) 是具有高灵敏度和特异性的潜在UC诊断标记物.
需要进行大规模的验证研究来确认V6 Ab的诊断效用.

研究的目的:

在全国多中心队列中验证V6 Ab对性结肠炎 (UC) 的诊断性能.
确定与UC患者假阴性和假阳性V6 Ab结果相关的因素.
评估V6 Ab诊断值在不同医疗机构的异质性.

主要方法:

在被诊断患有UC,克罗恩病 (CD) 或其他胃肠道疾病 (OGD) 的患者中测量了血清V6 Ab标位.
评估了V6 Ab对UC的诊断灵敏度和特异性.
采用多变量逻辑回归分析来识别影响假负和假阳性结果的因素.

主要成果:

这项研究包括来自28个中心的1241名UC,796名CD和206名OGD患者.
V6 Ab显示UC的诊断灵敏度为87.7%,CD的特异性为82.0%,OGD的特异性为87.4%.
与虚假阴性UC结果相关的因素包括年龄,吸烟,较低的疾病严重程度和缺乏先进疗法;结肠CD与虚假阳性结果有关.

结论:

对于性结肠炎 (UC) 的V6 Ab的诊断价值已经在一项大规模的全国性多中心研究中成功验证.
V6 Ab显示出作为UC诊断的可靠血清生物标志物的显著潜力.
该研究证实了参与中心的诊断性能一致.

关键词:

反整合素αvβ6抗体的抗体.结肠克罗恩氏病的疾病.诊断生物标志物的生物标志物.性结肠炎是一种

更多相关视频

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...